Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

VRTX US Equity

Vertex Pharmaceuticals Inc / MaHealth Care · Pharmaceutical Preparations · CIK 875320 · FY ends Dec 31
$552.06
+23.87 (+4.52%)
USD · as of 2026-08-19 · marketstack
8 8-K filings · 0 13D · 5 13G
DateEventWhat happened / filerSource
2026-08-038-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-07-078-K 8.01Other eventssec.gov ↗
2026-07-078-K 7.01Regulation FD disclosuresec.gov ↗
2026-07-078-K 1.01Entry into a material definitive agreementsec.gov ↗
2026-05-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Capital World Investorssec.gov ↗
2026-05-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Capital Research Global Investorssec.gov ↗
2026-05-138-K 5.07Submission of matters to a vote of security holderssec.gov ↗
2026-05-138-K 5.02Departure/election of directors or officers; compensationsec.gov ↗
2026-05-048-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-04-3013GSchedule 13G filed — ≥5% beneficial owner (passive) · by VANGUARD CAPITAL MANAGEMENT LLCsec.gov ↗
2026-04-298-K 5.02Departure/election of directors or officers; compensationsec.gov ↗
2026-03-318-K 8.01Other eventssec.gov ↗
2026-03-2713G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by VANGUARD GROUP INCsec.gov ↗
2026-02-128-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-02-1213G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Capital Research Global Investorssec.gov ↗
2025-11-038-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2025-11-03

Every row is a filed document, checked against its EDGAR index.